Skip to content

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

Professor Raphael Landovitz presenting to CROI 2021.

Therapeutic vaccine shows potential for HIV control off treatment in early study

Dr Beatriz Mothe (bottom left) presenting to CROI 2021.

HIV capsid inhibitor offers new option for people with highly resistant HIV

Professor Sorana Segal-Maurer (right) presenting to CROI 2021.

Underlying health conditions play a major role in increased risk of hospitalisation with COVID-19 in people with HIV

Dr Ming Lee (right) presenting to CROI 2021.

Depression, anxiety and loneliness can be improved with mindfulness audio lessons

Jeff Berko (right) presenting to CROI 2021.

Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda

Dr Mark Siedner (top right) presenting to CROI 2021.

Pronounced racial HIV disparities persist in the US, with some signs of slow improvement

Professor James Hildreth presenting to CROI 2021.

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

Professor Nicholas Paton (bottom, left) presenting to CROI 2021.

Alendronate can prevent bone loss in people starting HIV treatment

Dr Tara McGinty (centre, bottom) at CROI 2021.